Showing 2871-2880 of 10214 results for "".
Case Report: Flagellate Dermatitis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-flagellate-dermatitis/21206/Can Google Help with Difficult-to-Determine Etiology?Currents: Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-eczema-1/23743/Currents: Patient-Focused Approaches to Eczema
https://practicaldermatology.com/topics/atopic-dermatitis/currents-patient-focused-approaches-to-eczema/23444/What’s Old is New: Cosmetic Trends for 2020
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-old-is-new-cosmetic-trends-for-2020/23193/Experts go back to basics for best results.Type Casting: Assessing Personality Before a Hire
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/type-casting-assessing-personality-before-a-hire/22994/Can the Myers–Briggs Type Indicator take the guess work out of your next hiring decision?From the Neck Down
https://practicaldermatology.com/topics/practice-management/from-the-neck-down/20781/Exploring other uses for Allergan's KybellaMedical Credentialing
https://practicaldermatology.com/topics/practice-management/medical-credentialing/20948/You can help distinguish yourself from the masses by highlighting the unique credentials of your team.The Role of GLP-1RAs in Treating Inflammatory Dermatologic Diseases
https://practicaldermatology.com/issues/novemberdecember-2025/the-role-of-glp-1ras-in-treating-inflammatory-dermatologic-diseases/48899/Herein, we review the benefits and risks of GLP-1RAs with a focus on these 3 chronic inflammatory conditions.Teledermatology Use during the COVID-19 Pandemic
https://practicaldermatology.com/columns/clinical-focus-1/teledermatology-use-during-the-covid-19-pandemic/23769/Despite challenges, the future of teledermatology is promising.An Update on the Use of Trifarotene for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-trifarotene-for-the-treatment-of-acne/23267/Trifarotene is the first novel topical retinoid approved for the treatment of facial and truncal acne in 20 years.